Heart transplantation is a complex surgical procedure that replaces a severely damaged or failing heart with a healthy donor heart. It is considered for patients with advanced (end-stage) heart failure when optimal medical therapy, device therapy (such as implantable defibrillators), or mechanical circulatory support (e.g., ventricular assist devices) can no longer adequately sustain cardiac function.
Common underlying conditions include:
- Dilated cardiomyopathy
- Ischemic cardiomyopathy due to coronary artery disease
- Advanced valvular heart disease
- Congenital heart defects
- Refractory arrhythmias
- Severe myocarditis
The primary goal is to restore effective cardiac output, relieve debilitating symptoms (such as severe shortness of breath and fatigue), improve survival, and enhance quality of life.
Preparation Guidelines of Heart Transplantation
Comprehensive Transplant Evaluation
Before being listed, patients undergo a thorough multidisciplinary assessment involving cardiologists, transplant surgeons, anesthesiologists, pulmonologists, nephrologists, and infectious disease specialists, and social workers.
Evaluation typically includes:
- Echocardiography and cardiac MRI
- Right and left heart catheterization
- Cardiopulmonary exercise testing
- Pulmonary function testing
- Kidney and liver function assessment
- Screening for infection and malignancy
- Immunologic testing (HLA typing, panel reactive antibody testing)
Patients must demonstrate medical suitability, absence of active infection or malignancy, and the ability to adhere to long-term follow-up and immunosuppressive therapy.
Waiting Period
Organ allocation prioritizes urgency and medical need. Some patients may require temporary mechanical circulatory support while awaiting transplantation.
During the waiting period, patients must:
- Attend regular follow-up appointments
- Maintain optimized medical therapy
- Remain immediately reachable for organ offers
What to Expect
When a Donor Heart Becomes Available
When a compatible donor heart is identified, patients are admitted urgently. Final compatibility testing is performed before surgery.
During Surgery
The operation typically lasts 4 to 6 hours and is performed under general anesthesia. The procedure includes:
- Connecting the patient to a heart-lung bypass machine.
- Removing most of the failing heart while preserving portions of the atrial structures (in standard orthotopic transplantation).
- Implanting the donor heart.
- Reconnecting major blood vessels, including the aorta and pulmonary artery.
Once blood flow is restored, the new heart is assessed for immediate function.
Immediate Postoperative Care
After surgery:
- The patient is transferred to the ICU.
- Mechanical ventilation is usually required initially.
- Continuous monitoring of cardiac output, rhythm, blood pressure, and organ perfusion is performed.
- Immunosuppressive therapy is started immediately.
- Hospitalization typically lasts 2 to 3 weeks, depending on recovery.
Early Recovery
Rehabilitation begins early, focusing on:
- Gradual mobilization
- Respiratory exercises
- Medication education
- Monitoring for signs of rejection
Routine endomyocardial biopsies are commonly performed during the first year to detect early rejection.
Risks and Complications of Heart Transplantation
Early Complications
- Primary graft dysfunction
- Bleeding
- Infection
- Acute rejection
- Arrhythmias
Long-Term Complications
- Chronic rejection (cardiac allograft vasculopathy)
- Kidney dysfunction from immunosuppressive drugs
- Hypertension, diabetes, and lipid disorders
- Increased risk of certain malignancies
Despite these risks, long-term survival has improved significantly with modern immunosuppression and monitoring strategies.
Results and Follow-Up of Heart Transplantation
Most recipients experience marked improvement in exercise tolerance and symptom relief.
Long-term management includes:
- Lifelong immunosuppressive therapy
- Routine cardiac imaging
- Scheduled biopsies (especially in the first year)
- Coronary surveillance for transplant vasculopathy
- Cardiovascular risk factor control
Strict medication adherence and regular follow-up are essential to prevent rejection and preserve graft function.